Archives: “Archives”

Transmembrane domain–driven PD-1 dimers mediate T cell inhibition

https://www.coltonconsortium.org/publications/transmembrane-domain-driven-pd-1-dimers-mediate-t-cell-inhibition/

Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade

https://www.coltonconsortium.org/publications/substantiation-of-trophoblast-transport-of-maternal-anti-ssa-ro-autoantibodies-in-fetuses-with-rapidly-progressive-cardiac-injury-implications-for-neonatal-fc-receptor-blockade/

Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetes

https://www.coltonconsortium.org/publications/teplizumab-induces-persistent-changes-in-the-antigen-specific-repertoire-in-individuals-at-risk-for-type-1-diabetes/

Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium

https://www.coltonconsortium.org/publications/psoriatic-arthritis-phenotype-clusters-and-their-association-with-treatment-response-a-real-world-longitudinal-cohort-study-from-the-psoriatic-arthritis-research-consortium/

Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants

https://www.coltonconsortium.org/publications/kidney-multiome-based-genetic-scorecard-reveals-convergent-coding-and-regulatory-variants/

Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: a modified Delphi study

https://www.coltonconsortium.org/publications/personalized-treatment-decision-algorithms-for-the-clinical-application-of-serum-neurofilament-light-chain-in-multiple-sclerosis-a-modified-delphi-study/

Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity

https://www.coltonconsortium.org/publications/proximity-between-lag-3-and-the-t-cell-receptor-guides-suppression-of-t-cell-activation-and-autoimmunity/

Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

https://www.coltonconsortium.org/publications/crizanlizumab-for-retinal-vasculopathy-with-cerebral-leukoencephalopathy-in-a-phase-ii-clinical-study/

Decoding immunobiology through genetic errors of immunity

https://www.coltonconsortium.org/publications/decoding-immunobiology-through-genetic-errors-of-immunity/

Description of a novel splice site variant in UBA1 gene causing VEXAS syndrome

https://www.coltonconsortium.org/publications/description-of-a-novel-splice-site-variant-in-uba1-gene-causing-vexas-syndrome/